Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Эпидемиология гастроинтестинальных стромальных опухолей. Регистр в России: первый опыт
Эпидемиология гастроинтестинальных стромальных опухолей. Регистр в России: первый опыт
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Hirota S et al. Gain-of-mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577–80.
2. Kingham TP, DeMatteo RP. Multidisciplinary Treatment of Gastrointestinal Stromal Tumors. Surg Clin N Am 2009; 89: 217–33.
3. Nilsson B, Bumming P, Meis-Kindblom JM et al. Gastrointestinal Stromal Tumors: The Incidence, Prevelance, Clinical Course, and Prognostication in the Preimatinib Mesylate Era. Cancer 2005; 103 (4): 821–9.
4. Steigen SE, Tor J.Eide. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of Northern Norway. APMIS 2006; 114: 192–200.
5. Steigen SE, Bjerkehagen B, Haugland H et al. Diagnostic and prognostic markers for gastrointestinal stromal tumurs in Norway. Modern Pathology 2008; 21: 46–53.
6. Tryggvason G, Kristmundsson P, Orvar K et al. Clinical Study on Gastrointestinal Stromal Tumors (GIST) in Iceland, 1990–2003.
7. Goettsh WG, Bos SD, Breekveldt-Postma N et al. Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study. European Journal of Cancer 2005; 41: 2868–72.
8. Ahmed I, Welch NT, Parson SLP. EJSO 2008; 34: 445–9.
9. Mucciari C, Rossi G, Bertolini F et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007; 7 (230): 1–7.
10. Rubio J, Marcos-Gragera R, Ortiz MR et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur J Cancer 2007; 43: 144–8.
11. Perez EA, Livingstone AS, Franceschi D et al. Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors Including Gastrointestinal Stromal Tumors. J Am Coll Surg 2006; 202 (4): 623–9.
2. Kingham TP, DeMatteo RP. Multidisciplinary Treatment of Gastrointestinal Stromal Tumors. Surg Clin N Am 2009; 89: 217–33.
3. Nilsson B, Bumming P, Meis-Kindblom JM et al. Gastrointestinal Stromal Tumors: The Incidence, Prevelance, Clinical Course, and Prognostication in the Preimatinib Mesylate Era. Cancer 2005; 103 (4): 821–9.
4. Steigen SE, Tor J.Eide. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of Northern Norway. APMIS 2006; 114: 192–200.
5. Steigen SE, Bjerkehagen B, Haugland H et al. Diagnostic and prognostic markers for gastrointestinal stromal tumurs in Norway. Modern Pathology 2008; 21: 46–53.
6. Tryggvason G, Kristmundsson P, Orvar K et al. Clinical Study on Gastrointestinal Stromal Tumors (GIST) in Iceland, 1990–2003.
7. Goettsh WG, Bos SD, Breekveldt-Postma N et al. Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study. European Journal of Cancer 2005; 41: 2868–72.
8. Ahmed I, Welch NT, Parson SLP. EJSO 2008; 34: 445–9.
9. Mucciari C, Rossi G, Bertolini F et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007; 7 (230): 1–7.
10. Rubio J, Marcos-Gragera R, Ortiz MR et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur J Cancer 2007; 43: 144–8.
11. Perez EA, Livingstone AS, Franceschi D et al. Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors Including Gastrointestinal Stromal Tumors. J Am Coll Surg 2006; 202 (4): 623–9.
Авторы
М.П.Никулин, И.С.Стилиди
ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва
ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.